Los Angeles, CA – Wellth, a venture-backed digital health company that improves adherence in chronic disease populations, announced the close of its $20 million Series B funding round. Some prominent investors led the round which will be used to expand product offerings, hire additional staff and make strategic acquisitions.

Wellth uses the science of behavioral economics to uncover and address the unique obstacles that prevent people with chronic conditions from improving patient outcomes. Their program goes beyond current efforts to boost adherence with technology, reminders, and coaching solutions using contingency management and loss aversion to create motivation, and behavior change and improve population health at scale. To date, Wellth has been proven by health plans, providers, and other organizations to empower members with the incentives and support system they need to establish new healthy habits. Key outcomes for members include improved med and care plan adherence, reduction in readmissions, hospitalizations, ED utilization, and improved PDC (Prescription Drug Coverage).

“At Wellth we are on a mission to shift our healthcare system from one based on treating illness instead of preventing it," said Matthew Loper Co-Founder & CEO of Wellth. "Our platform puts individualized decision-making back into the hands of those managing their conditions.